D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
PayPal
PYPL
|
+$333M |
| 2 |
Microsoft
MSFT
|
+$311M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$310M |
| 4 |
Automatic Data Processing
ADP
|
+$260M |
| 5 |
Citigroup
C
|
+$255M |
Top Sells
| 1 |
APC
Anadarko Petroleum
APC
|
+$567M |
| 2 |
Fidelity National Information Services
FIS
|
+$410M |
| 3 |
Medtronic
MDT
|
+$374M |
| 4 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$288M |
| 5 |
Amazon
AMZN
|
+$278M |
Sector Composition
| 1 | Technology | 19.13% |
| 2 | Consumer Discretionary | 16.65% |
| 3 | Healthcare | 15.2% |
| 4 | Financials | 10.49% |
| 5 | Industrials | 8.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1426
Chemed
CHE
$6.5B
| $2.51M | ﹤0.01% |
6,015
-3,009
| -33% | -$1.26M |
|
1427
Tactile Systems Technology
TCMD
$301M
| $2.51M | ﹤0.01% |
59,329
-106,612
| -64% | -$4.51M |
|
1428
Oaktree Specialty Lending
OCSL
$1.21B
| $2.5M | ﹤0.01% |
160,781
-5,565
| -3% | -$86.5K |
|
1429
ANI Pharmaceuticals
ANIP
$2.12B
| $2.5M | ﹤0.01% |
34,249
+18,892
| +123% | +$1.38M |
|
1430
Hawaiian Electric Industries
HE
$2.09B
| $2.5M | ﹤0.01% |
54,714
+13,394
| +32% | +$611K |
|
1431
CytomX Therapeutics
CTMX
$330M
| $2.49M | ﹤0.01% |
337,004
+4,810
| +1% | +$35.5K |
|
|
CAI
1432
DELISTED
CAI International, Inc.
CAI
| $2.47M | ﹤0.01% |
113,382
-48,000
| -30% | -$1.04M |
|
1433
Amphenol
APH
$145B
| $2.47M | ﹤0.01% |
102,232
-372,208
| -78% | -$8.98M |
|
1434
Center Bancorp
CNOB
$1.26B
| $2.46M | ﹤0.01% |
111,012
-3,095
| -3% | -$68.7K |
|
1435
Red Robin
RRGB
$121M
| $2.44M | ﹤0.01% |
73,206
+51,460
| +237% | +$1.71M |
|
1436
UNIFI
UFI
$82.8M
| $2.43M | ﹤0.01% |
110,863
-22,337
| -17% | -$490K |
|
1437
Axsome Therapeutics
AXSM
$5.91B
| $2.43M | ﹤0.01% |
119,951
+85,195
| +245% | +$1.72M |
|
1438
Ralph Lauren
RL
$19.1B
| $2.43M | ﹤0.01% |
25,418
-40,817
| -62% | -$3.9M |
|
1439
Revvity
RVTY
$9.62B
| $2.43M | ﹤0.01% |
28,483
-51,843
| -65% | -$4.42M |
|
1440
Innospec
IOSP
$2.05B
| $2.42M | ﹤0.01% |
27,150
+6,556
| +32% | +$584K |
|
1441
Ingles Markets
IMKTA
$1.32B
| $2.42M | ﹤0.01% |
62,192
+32,626
| +110% | +$1.27M |
|
|
NXGN
1442
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $2.41M | ﹤0.01% |
153,862
-9,288
| -6% | -$146K |
|
|
BFX
1443
DELISTED
BowFlex Inc.
BFX
| $2.4M | ﹤0.01% |
1,779,017
+639,117
| +56% | +$863K |
|
|
HOLI
1444
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
| $2.39M | ﹤0.01% |
157,585
+95,155
| +152% | +$1.44M |
|
1445
UDR
UDR
$12.7B
| $2.39M | ﹤0.01% |
+49,349
| New | +$2.39M |
|
|
TVRD
1446
Tvardi Therapeutics, Inc. Common Stock
TVRD
$318M
| $2.39M | ﹤0.01% |
3,631
+2,419
| +200% | +$1.59M |
|
1447
First Financial Bankshares
FFIN
$5.12B
| $2.38M | ﹤0.01% |
71,404
-23,423
| -25% | -$781K |
|
1448
Ericsson
ERIC
$26.4B
| $2.38M | ﹤0.01% |
+297,967
| New | +$2.38M |
|
1449
FirstService
FSV
$9.31B
| $2.37M | ﹤0.01% |
23,100
+10,900
| +89% | +$1.12M |
|
1450
Assembly Biosciences
ASMB
$168M
| $2.37M | ﹤0.01% |
20,056
+15,632
| +353% | +$1.84M |
|